Peter Zimetbaum, MD
Zimetbaum P.; Atrial Fibrillation. Ann Intern Med. 2010;153:ITC6-1. doi: 10.7326/0003-4819-153-11-201012070-01006
Download citation file:
Published: Ann Intern Med. 2010;153(11):ITC6-1.
A trial fibrillation (AF) is the most common, clinically significant cardiac arrhythmia. It occurs when a diffuse and chaotic pattern of electrical activity in the atria suppresses or replaces the normal sinus mechanism, leading to deterioration of mechanical function. Atrial fibrillation is a major cause of morbidity, mortality, and health care expenditures; prevalence in the United States is 2.3 million cases and is estimated to increase to 5.6 million by the year 2050 (1). Atrial fibrillation is associated with a 5-fold increased risk for stroke and is estimated to cause 15% of all strokes (2). Independent of coexisting diseases, the presence of AF confers a 2-fold increased risk for all-cause mortality (3).
to gain full access to the content and tools.
Learn more about subscription options.
Register Now for a free account.
Cardiology, Rhythm Disorders and Devices.
Results provided by:
Copyright © 2016 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only